Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males.

BACKGROUND & AIMS Reported differences in cancer risk between male and female animals after chronic inflammation suggest that estrogen has inflammation-modifying properties. Little is known about these effects in human beings. Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC); we studied differences in inflammation-associated CRC between men and women patients with IBD. METHODS By using a large population-based cohort (n = 7607) of individuals diagnosed with IBD from 1954 to 1989, we assessed the sex-specific incidence of CRC from 1960 to 2004. Incidence was determined within the cohort (modeled using Poisson regression) and compared with the general population (assessed as standardized incidence ratios) using data from national Swedish health and census registers. RESULTS During 171,000 person-years of follow-up evaluation, 196 new cases of CRC were observed (123 in males, 73 in females). Males with IBD had a 60% higher risk of CRC (relative risk [RR], 1.6; 95% confidence interval [CI], 1.2-2.2) than females (cumulative incidence 40 years after IBD diagnosis, 8.3% vs 3.5%). Compared with the rate of CRC among the general population, in males with IBD the RR was 2.6 and the 95% CI was 2.2-3.1, whereas in females the RR was 1.9 and the 95% CI was 1.5-2.4. The effect of sex was limited to the period after 10 years of follow-up evaluation (RR, 0.8 before vs 2.2 after), and to patients diagnosed before age 45 (RR, 2.1 before vs 1.0 after). CONCLUSIONS IBD confers a lower risk of CRC to females than to males.

[1]  R. Virchow,et al.  Die krankhaften Geschwülste , 1978 .

[2]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[3]  H. Adami,et al.  Increased risk of large-bowel cancer in Crohn's disease with colonic involvement , 1990, The Lancet.

[4]  R. Medzhitov,et al.  Regulation of Spontaneous Intestinal Tumorigenesis Through the Adaptor Protein MyD88 , 2007, Science.

[5]  S. Vollset,et al.  Do reproductive factors influence colorectal cancer survival? , 1995, Journal of clinical epidemiology.

[6]  C. Probert,et al.  Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire , 1996, European journal of gastroenterology & hepatology.

[7]  A. Ahlbom,et al.  Crohn's disease and cancer: a population-based cohort study. , 1994, Gastroenterology.

[8]  A. Öst,et al.  Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. , 1990, Gastroenterology.

[9]  C. la Vecchia,et al.  Trends in cancer mortality sex ratios in Europe, 1950-1989. , 1992, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[10]  S. Kane,et al.  Hormonal Replacement Therapy After Menopause Is Protective of Disease Activity in Women With Inflammatory Bowel Disease , 2005, The American Journal of Gastroenterology.

[11]  M. Yashiro,et al.  Ulcerative Colitis-Associated Colorectal Cancer is Frequently Associated with the Microsatellite Instability Pathway , 2008, Diseases of the colon and rectum.

[12]  P. Munkholm,et al.  Intestinal cancer risk and mortality in patients with Crohn's disease. , 1993, Gastroenterology.

[13]  F. Carrat,et al.  Oral contraceptive use and the clinical course of Crohn’s disease: a prospective cohort study , 1999, Gut.

[14]  A. Ahlbom,et al.  Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study. , 1996, Gastroenterology.

[15]  F. Grodstein,et al.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis , 1999 .

[16]  R. Löfberg,et al.  Increased risk of cancer in ulcerative colitis: a population-based cohort study. , 1999 .

[17]  Alastair Forbes,et al.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. , 2004, Gastroenterology.

[18]  M. Picco.  Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease , 2009 .

[19]  Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis , 2001 .

[20]  H. Adami,et al.  The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. , 1991, Gastroenterology.

[21]  H. Adami,et al.  Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. , 1994, Gastroenterology.

[22]  R. Löfberg,et al.  Incidence of Crohn’s disease in Stockholm County 1955–1989 , 1997, Gut.

[23]  A. Ekbom.  Ulcerative Colitis and Colorectal Cancer , 1991 .

[24]  S. Baylin,et al.  Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon , 1994, Nature Genetics.

[25]  E. Kliewer,et al.  Cancer risk in patients with inflammatory bowel disease , 2001, Cancer.

[26]  A. Cohen,et al.  Patient nonadherence to medication in inflammatory bowel disease. , 2003 .

[27]  T. Louis,et al.  Hormone replacement therapy is associated with lower risk of adenomatous polyps of the large bowel: the Minnesota Cancer Prevention Research Unit Case-Control Study. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  R. Chlebowski,et al.  Estrogen plus progestin and colorectal cancer in postmenopausal women. , 2004, The New England journal of medicine.

[29]  P. Munkholm,et al.  Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[30]  J. Potter,et al.  Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer. , 2001, Cancer research.

[31]  H. Verspaget,et al.  Gender-related differences in the clinical course of Crohn's disease , 2001, American Journal of Gastroenterology.

[32]  L. Herrinton,et al.  Natural history of severe ulcerative colitis in a community-based health plan. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[33]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[34]  L. Melton,et al.  Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota. , 2006, Gastroenterology.

[35]  G. Hellers,et al.  Incidence of ulcerative colitis in Stockholm County 1955-1979. , 1985, Scandinavian journal of gastroenterology.

[36]  K. Abrams,et al.  Colorectal cancer prevention in ulcerative colitis: a case‐control study , 2000, Alimentary pharmacology & therapeutics.

[37]  L. Lix,et al.  Predictors of Medication Adherence in Inflammatory Bowel Disease , 2007, The American Journal of Gastroenterology.

[38]  Michael Karin,et al.  References and Notes Supporting Online Material Materials and Methods Som Text Figs. S1 to S6 Tables S1 to S4 Gender Disparity in Liver Cancer Due to Sex Differences in Myd88-dependent Il-6 Production , 2022 .

[39]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[40]  J. Terdiman,et al.  Effect of 5-Aminosalicylate Use on Colorectal Cancer and Dysplasia Risk: A Systematic Review and Metaanalysis of Observational Studies , 2005, The American Journal of Gastroenterology.